SS
Satya Saini
About Satya Saini
Data last updated:
Satya Saini is a Director at Musical Genome Private Limited (since 2019). The companies operate in Sports, Business Services and Internet. Musical Genome Private Limited reported revenue of ₹8.4 Lakh (FY 2025). Earlier, Satya Saini was a Director at Urbanmooserecords Private Limited (2018–2023) and Director at Mygigstar Technologies Private Limited (2016–2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 19 Jun 2019 | 2019 | ₹8.4 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Dec 2018 | 2018 | Active | ||
| Director | 23 Sep 2016 | 2016 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Satya Saini
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mohit Saini | 08297020 | Musical Genome Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Satya Saini
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Satya Saini
Satya Saini currently holds 1 directorship: Musical Genome Private Limited (Director, since 19 Jun 2019, revenue ₹8.4 Lakh (FY 2025)).
Satya Saini was first appointed on 23 Sep 2016 as Director at Mygigstar Technologies Private Limited. The most recent appointment on record is 19 Jun 2019 at Musical Genome Private Limited.
Satya Saini held 2 earlier board appointments: Urbanmooserecords Private Limited (Director, 06 Dec 2018 to 20 Jul 2023); Mygigstar Technologies Private Limited (Director, 23 Sep 2016 to 02 Jul 2019).
The current boards of Satya Saini's companies include Mohit Saini (Musical Genome Private Limited).